Cited by 207Sarcoma Diagnosis and TreatmentVeterinary Oncology ResearchCancer Cells and Metastasis

The DOI matches its Crossref record; 42 of the 42 references it cites were found in a registry or an index.

An orthotopic model of murine osteosarcoma with clonally related variants differing in pulmonary metastatic potential

Khanna, C., Prehn, J., Yeung, C., Caylor, J., Tsokos, M., Helman, L.·2000·Clinical & Experimental Metastasis

Open this paper in CoChat — free account

Abstract

To provide an investigative tool for the study of osteosarcoma (OSA) biology we have developed a syngeneic (balb/c) murine model of OSA, using cell lines derived from a spontaneously occurring murine OSA (Schmidt et al. Differentiation 1988; 39: 151-60). This model is characterized by orthotopic primary tumor growth, a period of minimal residual disease, spontaneous pulmonary metastasis, and clonally related variants (K7M2 and K12) that differ in pulmonary metastatic potential. Primary tumor and pulmonary metastasis histology was consistent with OSA in human patients. Expression of bone sialoprotein, biglyan, decorrin, and osteopontin was suggestive of bone lineage cells. The development and use of a more aggressive OSA cell line (K7M2) resulted in spontaneous metastasis to the lungs in over 90% of mice, whereas metastases were seen in only 33% of mice when a less aggressive OSA cell line (K12; Schmidt et al. Differentiation 1988; 39: 151-60) was used. Death from metastasis occurred at a median of 76 days using K7M2 whereas no median was achieved after 140 days using K12. Angiogenic potential, characterized by CD31 and factor VIII staining of primary tumors and pulmonary metastases, was greater in the K7M2 model compared to the K12 model. No significant differences in the in vitro or in vivo expression of angiogenesis associated genes (flt1, flt4, TIE1, TIE2, and VEGF) was found between K7M2 and K12. This well characterized and relevant model of OSA will be a valuable resource to improve our understanding of the biology and treatment of metastasis in OSA.

Integrity signals

Registry

Crossref · 10.1023/a:1006767007547

Cites

42 of 42 references verified0 citation errors · 0 not checkable

Statistics

Recomputing p-values needs the paper’s full text.

Claims the paper makes

This paper’s full text isn’t openly available, so its claims and self-check weren’t run. The registry and citation checks still apply.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Endostatin: an endogenous inhibitor of angiogenesis and tumor growth
O'Reilly, M. S., Boehm, T., Shing, Y., Fukai, N., Vasios, G., Lane, W. S., Flynn, E., Birkhead, J. R., Olsen, B. R., & Folkman, J. (1997) · Cell · doi:10.1016/s0092-8674(00)81848-6 · Cited by 4,486
Angiostatin: A novel angiogenesis inhibitor that mediates the suppression of metastases by a lewis lung carcinoma
OʼReilly, M. (1994) · Cell · doi:10.1016/0092-8674(94)90200-3 · Cited by 3,344
Vascular Channel Formation by Human Melanoma Cells in Vivo and in Vitro: Vasculogenic Mimicry
Maniotis, A. J., Folberg, R., Hess, A. R., Seftor, E. A., Gardner, L. M. G., Pe’er, J., Trent, J. M., Meltzer, P. S., & Hendrix, M. J. C. (1999) · American Journal Of Pathology · doi:10.1016/s0002-9440(10)65173-5 · Cited by 2,049
The pathogenesis of cancer metastasis
Poste, G. H., & Fidler, I. J. (1980) · Nature · doi:10.1038/283139a0 · Cited by 1,739
Tumor angiogenesis: past, present and the near future
Kerbel, R. S. (2000) · Carcinogenesis · doi:10.1093/carcin/21.3.505 · Cited by 985
Bone matrix RGD glycoproteins: Immunolocalization and interaction with human primary osteoblastic bone cells in vitro
Grzesik, W. J., & Robey, P. G. (1994) · Journal of Bone and Mineral Research · doi:10.1002/jbmr.5650090408 · Cited by 369
The Met/HGF receptor is over-expressed in human osteosarcomas and is activated by either a paracrine or an autocrine circuit.
Ferracini, R., Renzo, M. F. D., Scotlandi, K., Baldini, N., Olivero, M., Lollini, P., Cremona, O., Campanacci, M., & Comoglio, P. M. (1995) · PubMed · Cited by 280
Modulation of the Organ Microenvironment for Treatment of Cancer Metastasis
Fidler, I. J. (1995) · JNCI Journal of the National Cancer Institute · doi:10.1093/jnci/87.21.1588 · Cited by 240
Comparative Aspects of Osteosarcoma
Withrow, S. J., Powers, B. E., Straw, R. C., & Wilkins, R. M. (1991) · Clinical Orthopaedics and Related Research · doi:10.1097/00003086-199109000-00023 · Cited by 239
Angiogenesis Inhibitors Generated by Tumors
Folkman, J. (1995) · Molecular Medicine · doi:10.1007/bf03401559 · Cited by 219

Flagged first, then by citations

Show all 42 references

Sorted by citations

The membrane-cytoskeleton linker ezrin is necessary for osteosarcoma metastasis
Khanna, C., Wan, X., Bose, S., Cassaday, R., Olomu, O., Mendoza, A., Yeung, C., Gorlick, R., Hewitt, S. M., & Helman, L. J. (2004) · Nature Medicine · doi:10.1038/nm982 · Cited by 705
Self-citation
Osteosarcoma
Beird, H. C., Bielack, S. S., Flanagan, A. M., Gill, J., Heymann, D., Janeway, K. A., Livingston, J. A., Roberts, R. D., Strauss, S. J., & Gorlick, R. (2022) · Nature Reviews Disease Primers · doi:10.1038/s41572-022-00409-y · Cited by 660
Sarcoma Derived from Cultured Mesenchymal Stem Cells
Tolar, J., Nauta, A. J., Osborn, M. J., Mortari, A., McElmurry, R. T., Bell, S., Xia, L., Zhou, N., Riddle, M. J., Schroeder, T. M., et al. (2006) · Stem Cells · doi:10.1634/stemcells.2005-0620 · Cited by 643
Hypoxia: Importance in tumor biology, noninvasive measurement by imaging, and value of its measurement in the management of cancer therapy
Tatum, J. L. (2006) · International Journal of Radiation Biology · doi:10.1080/09553000601002324 · Cited by 626
Expression profiling identifies the cytoskeletal organizer ezrin and the developmental homeoprotein Six-1 as key metastatic regulators
Yu, Y., Khan, J. I., Khanna, C., Helman, L. J., Meltzer, P. S., & Merlino, G. T. (2004) · Nature Medicine · doi:10.1038/nm966 · Cited by 525
Self-citation
Germline and somatic genetics of osteosarcoma — connecting aetiology, biology and therapy
Gianferante, D. M., Mirabello, L. J., & Savage, S. A. (2017) · Nature Reviews Endocrinology · doi:10.1038/nrendo.2017.16 · Cited by 477
Modeling metastasis in vivo
Khanna, C. (2004) · Carcinogenesis · doi:10.1093/carcin/bgh261 · Cited by 476
Self-citation
Osteosarcoma Development and Stem Cell Differentiation
Tang, N., Song, W., Luo, J., Haydon, R. C., & He, T. (2008) · Clinical Orthopaedics and Related Research · doi:10.1007/s11999-008-0335-z · Cited by 365
Metastasis-associated differences in gene expression in a murine model of osteosarcoma.
Khanna, C., Khan, J. I., Nguyen, P., Prehn, J., Caylor, J., Yeung, C. L., Trepel, J. B., Meltzer, P. S., & Helman, L. J. (2001) · PubMed · Cited by 282
Self-citation
Molecular Pathogenesis of Osteosarcoma
Kansara, M., & Thomas, D. M. (2007) · DNA and Cell Biology · doi:10.1089/dna.2006.0505 · Cited by 280
CD117 and Stro-1 Identify Osteosarcoma Tumor-Initiating Cells Associated with Metastasis and Drug Resistance
Adhikari, A. S., Agarwal, N. A., Wood, B. M., Porretta, C. P., Ruiz, B. A., Pochampally, R. R., & Iwakuma, T. (2010) · Cancer Research · doi:10.1158/0008-5472.can-09-3463 · Cited by 261
Inhibition of the CXCR4/CXCL12 chemokine pathway reduces the development of murine pulmonary metastases
Kim, S. Y., Lee, C. H., Midura, B., Yeung, C. L., Mendoza, A., Hong, S. H., Ren, L., Wong, D., Korz, W., Merzouk, A., et al. (2007) · Clinical & Experimental Metastasis · doi:10.1007/s10585-007-9133-3 · Cited by 253
Self-citation
An Orthotopic Model of Human Osteosarcoma Growth and Spontaneous Pulmonary Metastasis
Luu, H. H., Kang, Q., Park, J. K., Si, W., Luo, Q., Jiang, W., Yin, H. X., MONTAG, A. G., Simon, M. A., Peabody, T. D., et al. (2005) · Clinical & Experimental Metastasis · doi:10.1007/s10585-005-0365-9 · Cited by 237
MicroRNA-34a Inhibits the Proliferation and Metastasis of Osteosarcoma Cells Both In Vitro and In Vivo
Yan, K., Gao, J., Yang, T.-T., Ma, Q., Qiu, X., Fan, Q., & Ma, B. (2012) · PLoS ONE · doi:10.1371/journal.pone.0033778 · Cited by 197
Biology of childhood osteogenic sarcoma and potential targets for therapeutic development: meeting summary.
Gorlick, R. G., Anderson, P. M., Andrulis, I. L., Arndt, C., Beardsley, G. P., Bernstein, M. L., Bridge, J. A., Cheung, N. V., Dome, J. S., Ebb, D. H., et al. (2003) · PubMed · Cited by 193
Self-citation
The anti-tumor effect of shikonin on osteosarcoma by inducing RIP1 and RIP3 dependent necroptosis
Fu, Z., Deng, B., Liao, Y., Shan, L., Yin, F., Wang, Z., Zeng, H. M., Zuo, D., Hua, Y., & Cai, Z. (2013) · BMC Cancer · doi:10.1186/1471-2407-13-580 · Cited by 181
miR-20a Encoded by the miR-17–92 Cluster Increases the Metastatic Potential of Osteosarcoma Cells by Regulating Fas Expression
Huang, G., Nishimoto, K., Zhou, Z., Hughes, D. P. M., & Kleinerman, E. S. (2011) · Cancer Research · doi:10.1158/0008-5472.can-11-1460 · Cited by 165
Positively selected enhancer elements endow osteosarcoma cells with metastatic competence
Morrow, J. J., Bayles, I., Funnell, A. P. W., Miller, T. E., Saiakhova, A., Lizardo, M. M., Bartels, C. F., Kapteijn, M. Y., Hung, S., Mendoza, A., et al. (2018) · Nature Medicine · doi:10.1038/nm.4475 · Cited by 161
Self-citation
MEK inhibition induces MYOG and remodels super-enhancers in RAS-driven rhabdomyosarcoma
Yohe, M. E., Gryder, B. E., Shern, J. F., Song, Y., Chou, H.-C., Sindiri, S., Mendoza, A., Patidar, R., Zhang, X., Guha, R., et al. (2018) · Science Translational Medicine · doi:10.1126/scitranslmed.aan4470 · Cited by 147
Blockade of the RhoA-JNK-c-Jun-MMP2 Cascade by Atorvastatin Reduces Osteosarcoma Cell Invasion
Fromigué, O., Hamidouche, Z., & Marie, P. J. (2008) · Journal of Biological Chemistry · doi:10.1074/jbc.m801436200 · Cited by 135
The actin-cytoskeleton linker protein ezrin is regulated during osteosarcoma metastasis by PKC
Ren, L., Hong, S., Cassavaugh, J. M., Osborne, T. S., Chou, A. J., Kim, S. Y., Gorlick, R. G., Hewitt, S. M., & Khanna, C. (2008) · Oncogene · doi:10.1038/onc.2008.437 · Cited by 134
Self-citation
Exosomal communication by metastatic osteosarcoma cells modulates alveolar macrophages to an M2 tumor-promoting phenotype and inhibits tumoricidal functions
Wolf-Dennen, K., Gordon, N. B., & Kleinerman, E. S. (2020) · OncoImmunology · doi:10.1080/2162402x.2020.1747677 · Cited by 128
Characterization of the metastatic phenotype of a panel of established osteosarcoma cells
Ren, L., Mendoza, A., Zhu, J., Briggs, J., Halsey, C., Hong, E. S., Burkett, S. S., Morrow, J. J., Lizardo, M. M., Osborne, T. S., et al. (2015) · Oncotarget · doi:10.18632/oncotarget.5177 · Cited by 116
Self-citation
Antagonism of chemokine receptor CXCR3 inhibits osteosarcoma metastasis to lungs
Pradelli, E., Karimdjee-Soilihi, B., Michiels, J., Ricci, J., Millet, M.-A., Burel‐Vandenbos, F., Sullivan, T. J., Collins, T. L., Johnson, M. G., Medina, J. C., et al. (2009) · International Journal of Cancer · doi:10.1002/ijc.24665 · Cited by 111
Osterix, a Transcription Factor for Osteoblast Differentiation, Mediates Antitumor Activity in Murine Osteosarcoma
Cao, Y., Zhou, Z., Crombrugghe, B. D., Nakashima, K., Guan, H., Duan, X., Jia, S.-F., & Kleinerman, E. S. (2005) · Cancer Research · doi:10.1158/0008-5472.can-04-2128 · Cited by 109
Establishment and characterization of a new highly metastatic human osteosarcoma cell line
Su, Y., Luo, X., He, B., Wang, Y., Liang, C., Zuo, G., Liu, B., Bi, Y., Huang, J., Zhu, G., et al. (2009) · Clinical & Experimental Metastasis · doi:10.1007/s10585-009-9259-6 · Cited by 104
Glutaminase-1 (GLS1) inhibition limits metastatic progression in osteosarcoma
Ren, L., Ruiz‐Rodado, V., Dowdy, T., Huang, S., Issaq, S. H., Beck, J. A., Wang, H., Hoang, C. D., Lita, A., Larion, M., et al. (2020) · Cancer & Metabolism · doi:10.1186/s40170-020-0209-8 · Cited by 102
Modeling metastasis biology and therapy in real time in the mouse lung
Mendoza, A., Hong, S.-H., Osborne, T., Khan, M. A., Campbell, K., Briggs, J., Eleswarapu, A., Buquo, L., Ren, L., Hewitt, S. M., et al. (2010) · Journal of Clinical Investigation · doi:10.1172/jci40252 · Cited by 92
Self-citation
Changes in cell shape are correlated with metastatic potential in murine and human osteosarcomas
Lyons, S. M., Alizadeh, E., Mannheimer, J., Schuamberg, K., Castle, J., Schroder, B., Turk, P. J., Thamm, D. H., & Prasad, A. (2016) · Biology Open · doi:10.1242/bio.013409 · Cited by 95
Enhanced anti-tumor activity and safety profile of targeted nano-scaled HPMA copolymer-alendronate-TNP-470 conjugate in the treatment of bone malignances
Segal, E., Pan, H., Benayoun, L., Kopečková, P., Shaked, Y., Kopeček, J., & Satchi‐Fainaro, R. (2011) · Biomaterials · doi:10.1016/j.biomaterials.2011.02.059 · Cited by 92
Commonly used mouse models of osteosarcoma
Ek, E. T., Dass, C. R., & Choong, P. (2006) · Critical Reviews in Oncology/Hematology · doi:10.1016/j.critrevonc.2006.03.006 · Cited by 87
Bisphosphonates Inhibit Osteosarcoma-Mediated Osteolysis Via Attenuation of Tumor Expression of MCP-1 and RANKL
Ohba, T., Cole, H., Cates, J., Slosky, D., Haro, H., Ando, T., Schwartz, H. S., & Schoenecker, J. G. (2014) · Journal of Bone and Mineral Research · doi:10.1002/jbmr.2182 · Cited by 84
Titanium surfaces with adherent selenium nanoclusters as a novel anticancer orthopedic material
Tran, P. A., Sarin, L., Hurt, R. H., & Webster, T. J. (2009) · Journal of Biomedical Materials Research Part A · doi:10.1002/jbm.a.32631 · Cited by 83
IL-6 and CXCL8 mediate osteosarcoma-lung interactions critical to metastasis
Gross, A. C., Cam, H., Phelps, D. A., Saraf, A. J., Bid, H. K., Cam, M., London, C. A., Winget, S. A., Arnold, M. A., Brandolini, L., et al. (2018) · JCI Insight · doi:10.1172/jci.insight.99791 · Cited by 82
Canine and murine models of osteosarcoma
Beck, J. A., Ren, L., Huang, S., Berger, E. P., Bardales, K., Mannheimer, J., Mazcko, C. N., & LeBlanc, A. K. (2022) · Veterinary Pathology · doi:10.1177/03009858221083038 · Cited by 84
Research models and mesenchymal/epithelial plasticity of osteosarcoma
Yu, X., Yustein, J. T., & Xu, J. (2021) · Cell & Bioscience · doi:10.1186/s13578-021-00600-w · Cited by 77
An unexpected role for a Wnt-inhibitor: Dickkopf-1 triggers a novel cancer survival mechanism through modulation of aldehyde-dehydrogenase-1 activity
Krause, U., Ryan, D. M., Clough, B. H., & Gregory, C. A. (2014) · Cell Death and Disease · doi:10.1038/cddis.2014.67 · Cited by 77
Notch Signaling is Associated with ALDH Activity and an Aggressive Metastatic Phenotype in Murine Osteosarcoma Cells
Mu, X., Isaac, C. E., Greco, N., Huard, J., & Weiss, K. R. (2013) · Frontiers in Oncology · doi:10.3389/fonc.2013.00143 · Cited by 77
Wnt10b induces chemotaxis of osteosarcoma and correlates with reduced survival
Chen, K., Fallen, S., Abaan, H. Ö., Hayran, M., Gonzalez, C., Wodajo, F., MacDonald, T., Toretsky, J. A., & Üren, A. (2008) · Pediatric Blood & Cancer · doi:10.1002/pbc.21595 · Cited by 74
A Review of the Association between Osteosarcoma Metastasis and Protein Translation
Osborne, T. S., & Khanna, C. (2012) · Journal of Comparative Pathology · doi:10.1016/j.jcpa.2011.12.007 · Cited by 73
Self-citation
Animal Models in Osteosarcoma
Guijarro, M. V., Ghivizzani, S. C., & Gibbs, C. P. (2014) · Frontiers in Oncology · doi:10.3389/fonc.2014.00189 · Cited by 73
Animal models of colorectal cancer with liver metastasis
Oh, B. Y., Hong, H. K., Lee, W. Y., & Cho, Y. B. (2016) · Cancer Letters · doi:10.1016/j.canlet.2016.01.048 · Cited by 71
Corruption of the Fas Pathway Delays the Pulmonary Clearance of Murine Osteosarcoma Cells, Enhances Their Metastatic Potential, and Reduces the Effect of Aerosol Gemcitabine
Gordon, N. B., Koshkina, N. V., Jia, S.-F., Khanna, C., Mendoza, A., Worth, L. L., & Kleinerman, E. S. (2007) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-07-0313 · Cited by 68
Self-citation
Osteoblastic and Osteolytic Human Osteosarcomas can be Studied With a New Xenograft Mouse Model Producing Spontaneous Metastases
Yuan, J. J., Ossendorf, C., Szatkowski, J. P., Bronk, J. T., Maran, A., Yaszemski, M. J., Bolander, M. E., Sarkar, G., & Fuchs, B. (2009) · Cancer Investigation · doi:10.1080/07357900802491477 · Cited by 66
Measuring systematic changes in invasive cancer cell shape using Zernike moments
Alizadeh, E., Lyons, S. M., Castle, J., & Prasad, A. (2016) · Integrative Biology · doi:10.1039/c6ib00100a · Cited by 65
Attenuated Salmonella typhimurium with IL-2 Gene Reduces Pulmonary Metastases in Murine Osteosarcoma
Sorenson, B. S., Banton, K. L., Frykman, N. L., Leonard, A. S., & Saltzman, D. A. (2008) · Clinical Orthopaedics and Related Research · doi:10.1007/s11999-008-0243-2 · Cited by 64
Testing of new agents in childhood cancer preclinical models: meeting summary.
Houghton, P. J., Adamson, P. C., Blaney, S. M., Fine, H. A., Gorlick, R. G., Haber, M., Helman, L. J., Hirschfeld, S., Hollingshead, M. G., Israel, M. A., et al. (2002) · PubMed · Cited by 63
Self-citation
Reprogramming Cancer into Antigen-Presenting Cells as a Novel Immunotherapy
Linde, M. H., Fan, A. C., Köhnke, T., Trotman-Grant, A. C., Gurev, S. F., Phan, P., Zhao, F., Haddock, N. L., Nuno, K. A., Gars, E. J., et al. (2023) · Cancer Discovery · doi:10.1158/2159-8290.cd-21-0502 · Cited by 61
Murine leukemia virus envelope gp70 is a shared biomarker for the high-sensitivity quantification of murine tumor burden
Scrimieri, F., Askew, D., Corn, D. J., Eid, S. K., Bobanga, I., Bjelac, J. A., Tsao, M. L., Allen, F., Othman, Y., Wang, S.-C. G., et al. (2013) · OncoImmunology · doi:10.4161/onci.26889 · Cited by 59
Inhibition of Tumor Cell Motility by the Interferon-inducible GTPase MxA
Mushinski, J. F., Nguyen, P., Stevens, L. M., Khanna, C., Lee, S., Chung, E. J., Lee, M.-J., Kim, Y. S., Linehan, W. M., Horisberger, M. A., et al. (2009) · Journal of Biological Chemistry · doi:10.1074/jbc.m806324200 · Cited by 58
Self-citation
Autocrine VEGF/VEGFR1 Signaling in a Subpopulation of Cells Associates with Aggressive Osteosarcoma
Ohba, T., Cates, J., Cole, H., Slosky, D., Haro, H., Ando, T., Schwartz, H. S., & Schoenecker, J. G. (2014) · Molecular Cancer Research · doi:10.1158/1541-7786.mcr-14-0037 · Cited by 58
CD1d-Restricted Natural Killer T Cells Can Down-regulate Tumor Immunosurveillance Independent of Interleukin-4 Receptor-Signal Transducer and Activator of Transcription 6 or Transforming Growth Factor-β
Terabe, M., Khanna, C., Bose, S., Melchionda, F., Mendoza, A., Mackall, C. L., Helman, L. J., & Berzofsky, J. A. (2006) · Cancer Research · doi:10.1158/0008-5472.can-05-3421 · Cited by 57
Self-citation
Oncolytic Semliki Forest Virus Vector as a Novel Candidate against Unresectable Osteosarcoma
Ketola, A., Hinkkanen, A., Yongabi, F. N., Furu, P. T., Määttä, A., Liimatainen, T., Pirinen, R. T., Björn, M. H., Hakkarainen, T., Mäkinen, K., et al. (2008) · Cancer Research · doi:10.1158/0008-5472.can-08-0251 · Cited by 53
Ezrin Inhibition Up-regulates Stress Response Gene Expression
Çelik, H., Bulut, G., Han, J. J., Graham, G. T., Minas, T. Z., Conn, E. J., Hong, S.-H., Pauly, G. T., Hayran, M., Li, X., et al. (2016) · Journal of Biological Chemistry · doi:10.1074/jbc.m116.718189 · Cited by 53
Rapamycin Inhibits ALDH Activity, Resistance to Oxidative Stress, and Metastatic Potential in Murine Osteosarcoma Cells
Mu, X., Isaac, C. E., Schott, T., Huard, J., & Weiss, K. R. (2013) · Sarcoma · doi:10.1155/2013/480713 · Cited by 50
Dysregulation of Ezrin Phosphorylation Prevents Metastasis and Alters Cellular Metabolism in Osteosarcoma
Ren, L., Hong, S.-H., Chen, Q.-R., Briggs, J., Cassavaugh, J., Srinivasan, S., Lizardo, M. M., Mendoza, A., Xia, A. Y., Avadhani, N., et al. (2012) · Cancer Research · doi:10.1158/0008-5472.can-11-0210 · Cited by 50
Self-citation
Inhibition of AP-1 Transcriptional Activity Blocks the Migration, Invasion, and Experimental Metastasis of Murine Osteosarcoma
Leaner, V. D., Chick, J. F. B., Donninger, H., Linniola, I., Mendoza, A., Khanna, C., & Birrer, M. J. (2008) · American Journal Of Pathology · doi:10.2353/ajpath.2009.071006 · Cited by 50
Self-citation
VEGF and BMP Expression in Mouse Osteosarcoma Cells
Weiss, K. R., Cooper, G. M., Jadlowiec, J. A., McGough, R. L., & Huard, J. (2006) · Clinical Orthopaedics and Related Research · doi:10.1097/01.blo.0000229333.98781.56 · Cited by 48
The combination of eddy thermal effect of biodegradable magnesium with immune checkpoint blockade shows enhanced efficacy against osteosarcoma
Ge, J., Yang, N., Yang, Y., Yu, H., Yang, X., Wang, Y., Wang, T., Cheng, S., Wang, Y., Han, Z., et al. (2023) · Bioactive Materials · doi:10.1016/j.bioactmat.2023.01.008 · Cited by 47
Targeted inhibition of T-cell factor activity promotes syndecan-2 expression and sensitization to doxorubicin in osteosarcoma cells and bone tumors in mice
Dieudonné, F., Marion, A., Marie, P. J., & Modrowski, D. (2012) · Journal of Bone and Mineral Research · doi:10.1002/jbmr.1650 · Cited by 47
Interactions between osteopontin and vascular endothelial growth factor: Implications for cancer
Ramchandani, D., & Weber, G. F. (2015) · Biochimica et Biophysica Acta (BBA) - Reviews on Cancer · doi:10.1016/j.bbcan.2015.02.003 · Cited by 47
Metabolomics uncovers a link between inositol metabolism and osteosarcoma metastasis
Ren, L., Hong, E. S., Mendoza, A., Issaq, S. H., Hoang, C. T., Lizardo, M. M., LeBlanc, A. K., & Khanna, C. (2017) · Oncotarget · doi:10.18632/oncotarget.15872 · Cited by 46
Self-citation
FHL2 Silencing Reduces Wnt Signaling and Osteosarcoma Tumorigenesis In Vitro and In Vivo
Brun, J., Dieudonné, F., Marty, C., Müller, J. M., Schüle, R., Patiño‐García, A., Lecanda, F., Fromigué, O., & Marie, P. J. (2013) · PLoS ONE · doi:10.1371/journal.pone.0055034 · Cited by 46
Pleiotropic effects of bisphosphonates on osteosarcoma
Ohba, T., Cates, J., Cole, H., Slosky, D., Haro, H., Ichikawa, J., Ando, T., Schwartz, H. S., & Schoenecker, J. G. (2014) · Bone · doi:10.1016/j.bone.2014.03.005 · Cited by 45
Humanization of bone and bone marrow in an orthotopic site reveals new potential therapeutic targets in osteosarcoma
Wagner, F., Holzapfel, B. M., McGovern, J., Shafiee, A., Baldwin, J., Martine, L. C., Lahr, C. A., Wunner, F. M., Friis, T., Bas, O., et al. (2018) · Biomaterials · doi:10.1016/j.biomaterials.2018.04.030 · Cited by 46
An orthotopic xenograft model with survival hindlimb amputation allows investigation of the effect of tumor microenvironment on sarcoma metastasis
Goldstein, S. D., Hayashi, M., Albert, C. M., Jackson, K. W., & Loeb, D. M. (2015) · Clinical & Experimental Metastasis · doi:10.1007/s10585-015-9738-x · Cited by 45
Understanding the Role of Notch in Osteosarcoma
McManus, M. M., Weiss, K. R., & Hughes, D. P. M. (2014) · Advances in experimental medicine and biology · doi:10.1007/978-3-319-04843-7_4 · Cited by 47
Notch Signaling Mediates Skeletal Muscle Atrophy in Cancer Cachexia Caused by Osteosarcoma
Mu, X., Agarwal, R., March, D., Rothenberg, A. C., Voigt, C., Tebbets, J. C., Huard, J., & Weiss, K. R. (2016) · Sarcoma · doi:10.1155/2016/3758162 · Cited by 45
The Role of Fas/FasL in the Metastatic Potential of Osteosarcoma and Targeting this Pathway for the Treatment of Osteosarcoma Lung Metastases
Gordon, N. B., & Kleinerman, E. S. (2009) · Cancer treatment and research · doi:10.1007/978-1-4419-0284-9_29 · Cited by 44
Tumor secreted ANGPTL2 facilitates recruitment of neutrophils to the lung to promote lung pre-metastatic niche formation and targeting ANGPTL2 signaling affects metastatic disease
Charan, M., Dravid, P., Cam, M., Setty, B., Roberts, R. D., Houghton, P. J., & Cam, H. (2020) · Oncotarget · doi:10.18632/oncotarget.27433 · Cited by 41
Genomic Instability of Osteosarcoma Cell Lines in Culture: Impact on the Prediction of Metastasis Relevant Genes
Muff, R., Rath, P., Kumar, R. M. R., Husmann, K., Born, W., Baudis, M., & Fuchs, B. (2015) · PLoS ONE · doi:10.1371/journal.pone.0125611 · Cited by 46
Gefitinib Inhibits Invasion and Metastasis of Osteosarcoma via Inhibition of Macrophage Receptor Interacting Serine-Threonine Kinase 2
Maloney, C. W., Kallis, M. P., Edelman, M. C., Tzanavaris, C., LESSER, M. L., Soffer, S. Z., Symons, M. H., & Steinberg, B. M. (2020) · Molecular Cancer Therapeutics · doi:10.1158/1535-7163.mct-19-0903 · Cited by 41
Human xenograft osteosarcoma models with spontaneous metastasis in mice: clinical relevance and applicability for drug testing
Dass, C. R., Ek, E. T., & Choong, P. (2006) · Journal of Cancer Research and Clinical Oncology · doi:10.1007/s00432-006-0157-x · Cited by 42
Intratibial Injection Causes Direct Pulmonary Seeding of Osteosarcoma Cells and Is Not a Spontaneous Model of Metastasis: A Mouse Osteosarcoma Model
Maloney, C. W., Edelman, M. C., Kallis, M. P., Soffer, S. Z., Symons, M. H., & Steinberg, B. M. (2018) · Clinical Orthopaedics and Related Research · doi:10.1007/s11999.0000000000000291 · Cited by 40
Aerosol Therapy for the Treatment of Osteosarcoma Lung Metastases: Targeting the Fas/FasL Pathway and Rationale for the Use of Gemcitabine
Gordon, N. B., & Kleinerman, E. S. (2010) · Journal of Aerosol Medicine and Pulmonary Drug Delivery · doi:10.1089/jamp.2009.0812 · Cited by 40
Increased expression of metastasis-related genes in hypoxic cells sorted from cervical and lymph nodal xenograft tumors
Chaudary, N., & Hill, R. P. (2009) · Laboratory Investigation · doi:10.1038/labinvest.2009.16 · Cited by 40
Genes Regulated in Metastatic Osteosarcoma: Evaluation by Microarray Analysis in Four Human and Two Mouse Cell Line Systems
Muff, R., Kumar, R. M. R., Botter, S. M., Born, W., & Fuchs, B. (2012) · Sarcoma · doi:10.1155/2012/937506 · Cited by 41
Knockdown of autophagy-related protein 5, ATG5, decreases oxidative stress and has an opposing effect on camptothecin-induced cytotoxicity in osteosarcoma cells
Hollomon, M. G., Gordon, N. B., Santiago‐O’Farrill, J. M., & Kleinerman, E. S. (2013) · BMC Cancer · doi:10.1186/1471-2407-13-500 · Cited by 42
Histone deacetylase inhibition prevents the growth of primary and metastatic osteosarcoma
McGuire, J., Nerlakanti, N., Lo, C. H., Tauro, M., Utset‐Ward, T. J., Reed, D. R., & Lynch, C. C. (2020) · International Journal of Cancer · doi:10.1002/ijc.33046 · Cited by 40
Osteocytes Serve as a Progenitor Cell of Osteosarcoma
Sottnik, J. L., Campbell, B., Mehra, R., Behbahani‐Nejad, O., Hall, C. L., & Keller, E. T. (2014) · Journal of Cellular Biochemistry · doi:10.1002/jcb.24793 · Cited by 37
Establishment and characterization of human osteosarcoma cell lines with different pulmonary metastatic potentials
Chen, X., Yang, T.-T., Wang, W., Sun, H., Ma, B., Li, C., Ma, Q., Yu, Z., & Fan, Q. (2009) · Cytotechnology · doi:10.1007/s10616-009-9239-3 · Cited by 37
HACE1 is a potential tumor suppressor in osteosarcoma
El-Naggar, A. M., Clarkson, P. W., Negri, G. L., Turgu, B., Zhang, F., Anglesio, M. S., & Sorensen, P. H. B. (2019) · Cell Death and Disease · doi:10.1038/s41419-018-1276-4 · Cited by 37
Calpain‐6 is an endothelin‐1 signaling dependent protective factor in chemoresistant osteosarcoma
Marion, A., Dieudonné, F., Patiño‐García, A., Lecanda, F., Marie, P. J., & Modrowski, D. (2011) · International Journal of Cancer · doi:10.1002/ijc.26246 · Cited by 37
Thrombin induces osteosarcoma growth, a function inhibited by low molecular weight heparin in vitro and in vivo: Procoagulant nature of osteosarcoma
Ichikawa, J., Cole, H. A., Magnussen, R. A., Mignemi, N. A., Butler, M., Holt, G. E., O'Rear, L., Yuasa, M., Pabla, B., Haro, H., et al. (2012) · Cancer · doi:10.1002/cncr.26518 · Cited by 36
Osteosarcoma Models: From Cell Lines to Zebrafish
Mohseny, A. B., Hogendoorn, P. C. W., & Cleton-Jansen, A. (2012) · Sarcoma · doi:10.1155/2012/417271 · Cited by 36
Xenograft and genetically engineered mouse model systems of osteosarcoma and Ewing's sarcoma: tumor models for cancer drug discovery
Sampson, V. B., Kamara, D., & Kolb, E. A. (2013) · Expert Opinion on Drug Discovery · doi:10.1517/17460441.2013.817988 · Cited by 37
p27 Is a Candidate Prognostic Biomarker and Metastatic Promoter in Osteosarcoma
Li, Y., Nakka, M., Kelly, A. J., Lau, C. C., Krailo, M., Barkauskas, D. A., Hicks, J. M., & Man, T. (2016) · Cancer Research · doi:10.1158/0008-5472.can-15-3189 · Cited by 36
Small-Molecule Procaspase-3 Activation Sensitizes Cancer to Treatment with Diverse Chemotherapeutics
Botham, R. C., Roth, H. S., Book, A. P., Roady, P. J., Fan, T. M., & Hergenrother, P. J. (2016) · ACS Central Science · doi:10.1021/acscentsci.6b00165 · Cited by 35
Immune reconstitution prevents metastatic recurrence of murine osteosarcoma
Merchant, M. S., Melchionda, F., Sinha, M. L., Khanna, C., Helman, L. J., & Mackall, C. L. (2006) · Cancer Immunology Immunotherapy · doi:10.1007/s00262-006-0257-0 · Cited by 35
Self-citation
Protein kinase C regulates ezrin–radixin–moesin phosphorylation in canine osteosarcoma cells
Hong, S. ‐., Osborne, T. S., Ren, L., Briggs, J., Mazcko, C. N., Burkett, S. S., & Khanna, C. (2010) · Veterinary and Comparative Oncology · doi:10.1111/j.1476-5829.2010.00249.x · Cited by 35
Self-citation
Assessing Growth and Response to Therapy in Murine Tumor Models
Reynolds, C. P., Sun, B.-C., DeClerck, Y. A., & Moats, R. A. (2005) · Humana Press eBooks · doi:10.1385/1-59259-889-7:335 · Cited by 35
Injectable Tumor Microenvironment-Modulated Hydrogels with Enhanced Chemosensitivity and Osteogenesis for Tumor-Associated Bone Defects Closed-Loop Management
Cai, M., Li, X., Xu, M., Zhou, S., Fan, L., Huang, J., Xiao, C., Lee, Y., Yang, B., Wang, L., et al. (2022) · Chemical Engineering Journal · doi:10.1016/j.cej.2022.138086 · Cited by 34
Pulmonary Metastasectomy for Osteosarcoma: Is It Justified?
Diemel, K., Klippe, H. J., & Branscheid, D. (2009) · Recent results in cancer research/Recent Results in Cancer Research · doi:10.1007/978-3-540-77960-5_12 · Cited by 33
The Clinical Relevance of Molecular Genetics in Soft Tissue Sarcomas
Ordóñez, J. L., Osuna, D., García-Domínguez, D. J., Amaral, A. T., Otero-Motta, A. P., Mackintosh, C., Sevillano, V., Barbado, M. V., Hernández, T., & de Álava, E. (2010) · Advances in Anatomic Pathology · doi:10.1097/pap.0b013e3181d98cbf · Cited by 34
Notch signaling regulates osteosarcoma proliferation and migration through Erk phosphorylation
Qin, J., Wang, R., Zhao, C., Wen, J., Dong, H., Wang, S., Li, Y., Zhao, Y., Li, J.-J., Yang, Y., et al. (2019) · Tissue and Cell · doi:10.1016/j.tice.2019.07.002 · Cited by 31
High VEGF with Rapid Growth and Early Metastasis in a Mouse Osteosarcoma Model
Yang, S., Yu, H., Krygier, J. E., Wooley, P. H., & Mott, M. (2007) · Sarcoma · doi:10.1155/2007/95628 · Cited by 31
The HDAC Inhibitor Vorinostat Diminishes theIn VitroMetastatic Behavior of Osteosarcoma Cells
Mu, X., Brynien, D., & Weiss, K. R. (2015) · BioMed Research International · doi:10.1155/2015/290368 · Cited by 31
Targeting Inflammatory Kinase as an Adjuvant Treatment for Osteosarcomas
Noh, K.-C., Kim, K.-O., Patel, N., Staples, J. R., Minematsu, H., Nair, K., & Lee, F. Y. (2011) · Journal of Bone and Joint Surgery · doi:10.2106/jbjs.j.00302 · Cited by 30
Establishment of human osteosarcoma cell lines with high metastatic potential to lungs and their utilities for therapeutic studies on metastatic osteosarcoma
Kimura, K., 中野, 哲., Park, Y.-B., Tani, M., Tsuda, H., Beppu, Y., Moriya, H., & Yokota, J. (2002) · Clinical & Experimental Metastasis · doi:10.1023/a:1020395816633 · Cited by 29
Do mesenchymal stromal cells influence microscopic residual or metastatic osteosarcoma in a murine model?
Aanstoos, M. E., Regan, D. P., Rose, R. J., Chubb, L. S., & Ehrhart, N. P. (2016) · Clinical Orthopaedics & Related Research · doi:10.1007/s11999-015-4362-2 · Cited by 28

Authors: Khanna, C., Prehn, J., Yeung, C., Caylor, J., Tsokos, M., & Helman, L.
Affiliations: National Institutes of Health (US)
ORCID: Yeung, C.
Tsokos, M.
Helman, L.
Venue: Clinical & Experimental Metastasis
Publisher: Springer Science and Business Media LLC
Published: 2000-05
Volume: 18
Issue: 3
Pages: 261-271
ISSN: 0262-0898 (ISSN-L)
1573-7276
DOI: 10.1023/a:1006767007547
OpenAlex: W19745091
Cited by: 207
References: 42
Citations by year: 2026: 7 · 2025: 9 · 2024: 9 · 2023: 4 · 2022: 4 · 2021: 4 · 2020: 15 · 2019: 6 · 2018: 9 · 2017: 4 · 2016: 11 · 2015: 8 · 2014: 14 · 2013: 15 · 2012: 11
FWCI: 1.46
Type: journal article
Language: en
Open access: closed
Licence: www.springernature.com/gp/researchers/text-and-data-mining (tdm)
www.springernature.com/gp/researchers/text-and-data-mining (vor)
Locations: Clinical & Experimental Metastasis (publishedVersion)
PubMed (publishedVersion)
Topics: Health Sciences › Medicine › Oncology › Sarcoma Diagnosis and Treatment
Health Sciences › Veterinary › Small Animals › Veterinary Oncology Research
Health Sciences › Medicine › Oncology › Cancer Cells and Metastasis
Keywords: osteosarcoma, orthotopic tumor model, syngeneic murine model, lung metastasis, tumor angiogenesis, CD31, factor VIII, vascular endothelial growth factor, bone sialoprotein, osteopontin, biglycan, decorin, metastatic potential
MeSH terms: Animals, Bone Neoplasms, Female, Lung Neoplasms, Mice, Inbred BALB C, Models, Biological, Osteosarcoma, Survival Analysis, Mice

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

An orthotopic model of murine osteosarcoma with clonally related variants differing in pulmonary metastatic potential

Abstract

Overview

Integrity signals

Verification

Claims the paper makes

Claims other papers make about this one

Citations

Cites

Cited by

Related

Metadata

Record

About these checks